Fast-Track support for Strategic Investments in Portugal
Developing large-scale projects in Portugal can be a complex journey, requiring coordination across multiple stages and entities. However, securing Portuguese Important Project (PIN) or Investment Project for the Interior (PII) status unlocks a powerful advantage—streamlining approvals and accelerating progress.
With direct support from key governmental bodies such as APA, CCDR, Floene, REN, and others, investors benefit from: ✔ Priority in licensing – ensuring faster approvals ✔ Simultaneous administrative processing – cutting through bureaucracy ✔ Significant reduction in timelines – getting projects off the ground quicker
For those looking to invest in Portugal, PIN/PII status is the key to unlocking efficiency and success.
The project is formed by 88 entities and is led by Prológica, Sistemas Informáticos S.A.. The aim of HfPT - Health from Portugal is to position Portugal as a world reference hub in the design, development and production of advanced solutions for the health market, based on innovation and technology. HfPT will focus on 4 areas of activity:
Development of smart health solutions aimed at the digital medtech segment;
Creation of a national smart health data repository of international reference; Training for the growth and sophistication of the clinical studies segment in the country; and
Creating solutions that enhance the potential of the ecosystem for collecting and benchmarking clinical data and costs associated with healthcare provision.
Objectives, activities and expected results The aim of this project is to develop a local hospital platform that will make it possible to implement an integrated clinical governance model centered on the patient and their clinical condition, as well as to develop and produce new technological solutions in the area of collecting and integrating patient-generated data into healthcare systems. The new products to be launched will enable better management and treatment in different clinical areas, evaluating and identifying results from the patient's point of view (PROMs), as well as the experience reported by the patient (PREMs).
The project started in November 2021 and is expected to be completed in December 2025. It is co-financed by the Recovery and Resilience Plan (RRP) under Component C5: Capitalization and Business Innovation (- Agendas/Alliances mobilizing for Business Innovation) and involves a total investment of around EUR 90M and financial support from the European Union of EUR 70M.
